Lola E. Navas
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Physiology top 5%
- Calcium signaling and nucleotide metabolism
Papers in
- Oncology 4
- Cancer Cells and Metastasis 2
- Peptidase Inhibition and Analysis 1
- PARP inhibition in cancer therapy 1
-
- Cancer-related gene regulation 1
- Signaling Pathways in Disease 1
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Amancio Carnero (8 shared papers)Masayuki Umeda (1 shared paper)Antonio Lucena-Cacace (1 shared paper)Blanca Felipe‐Abrio (3 shared papers)Eva M. Verdugo‐Sivianes (5 shared papers)Sandra Muñoz-Galván (4 shared papers)José Manuel García-Heredia (2 shared papers)Juan Marín (2 shared papers)
In The Last Decade
Lola E. Navas
7 papers receiving 403 citations
Lola E. Navas's Hit Papers
Peers
Comparison fields: 5 of 81
- Geriatrics and Gerontology 97
- Physiology 56
- Biological Psychiatry 25
- Cancer Research 82
- Oncology 121
Countries citing papers authored by Lola E. Navas
This map shows the geographic impact of Lola E. Navas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lola E. Navas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lola E. Navas more than expected).
Fields of papers citing papers by Lola E. Navas
This network shows the impact of papers produced by Lola E. Navas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lola E. Navas. The network helps show where Lola E. Navas may publish in the future.
Co-authors
The 23 scholars most cited alongside Lola E. Navas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | NAD+ metabolism, stemness, the immune response, and cancer Hit paper breakdown → | 2021 | 320 |
| 2 | 2019 | 34 | |
| 3 | 2019 | 27 | |
| 4 | 2017 | 16 | |
| 5 | 2023 | 7 | |
| 6 | 2016 | 2 | |
| 7 | 2018 | 1 | |
| 8 | 2018 | 0 |
About Lola E. Navas
Lola E. Navas is a scholar working on Oncology, Molecular Biology, Geriatrics and Gerontology, Epidemiology and Physiology, having authored 8 papers that have together received 407 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Cancer Cells and Metastasis (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer-related gene regulation (1 paper), Signaling Pathways in Disease (1 paper), PARP inhibition in cancer therapy (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Geriatrics and Gerontology (97 citations), Physiology (56 citations), Biological Psychiatry (25 citations), Cancer Research (82 citations) and Oncology (121 citations). Lola E. Navas has collaborated with scholars based in Spain, Australia and Japan. Frequent co-authors include Amancio Carnero, Masayuki Umeda, Antonio Lucena-Cacace, Blanca Felipe‐Abrio, Eva M. Verdugo‐Sivianes, Sandra Muñoz-Galván, José Manuel García-Heredia, Juan Marín, Adoración G. Quiroga and Daniel Otero-Albiol. Their work appears in journals such as ESMO Open, Journal of Experimental & Clinical Cancer Research, Frontiers in Oncology, Oncotarget and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.